ATXS - Astria Therapeutics, Inc. Stock Price, Fair Value and News

$13.09+0.49 (+3.89%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ATXS Price Action

Last 7 days

3.9%

Last 30 days

5.7%

Last 90 days

87%

Trailing 12 Months

28.0%

ATXS RSI Chart

ATXS Valuation

Market Cap

747.2M

Price/Earnings (Trailing)

-6.02

Price/Free Cashflow

-5.96

ATXS Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ATXS Fundamentals

ATXS Revenue

Rev. Growth (Yr)

106.92%

Rev. Growth (Qtr)

14.83%

ATXS Earnings

Earnings (TTM)

-124.0M

Earnings Growth (Yr)

-28.98%

Earnings Growth (Qtr)

4.26%

ATXS Profitability

Return on Equity

-53.17%

Return on Assets

-45.62%

Free Cashflow Yield

-16.77%

ATXS Investor Care

Shares Dilution (1Y)

1.15%

Diluted EPS (TTM)

-2.14

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	0	0	0	0
2024	0	0	0	0
2017	0	0	0	500.0K

Get all data in R, Python etc through our Historical Stock Data APIs

About Astria Therapeutics, Inc.

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in clinical development stage for the treatment of hereditary angioedema. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts.

CEO	Ms. Jill C. Milne Ph.D.
WEBSITE	astriatx.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	45

Astria Therapeutics, Inc. Frequently Asked Questions

What is the ticker symbol for Astria Therapeutics, Inc.? What does ATXS stand for in stocks?

ATXS is the stock ticker symbol of Astria Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Astria Therapeutics, Inc. (ATXS)?

As of Wed Dec 03 2025, market cap of Astria Therapeutics, Inc. is 747.24 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ATXS stock?

You can check ATXS's fair value in chart for subscribers.

Is Astria Therapeutics, Inc. a good stock to buy?

The fair value guage provides a quick view whether ATXS is over valued or under valued. Whether Astria Therapeutics, Inc. is cheap or expensive depends on the assumptions which impact Astria Therapeutics, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ATXS.

What is 5 year return on Astria Therapeutics, Inc.'s stock?

In the past 10 years, Astria Therapeutics, Inc. has provided -0.31 (multiply by 100 for percentage) rate of return.